| P50 | author | Georg Halder | Q43108514 |
| | Fernando Camargo | Q90424896 |
| P2860 | cites work | Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling | Q24294906 |
| | Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus | Q24300692 |
| | Role of TAZ as mediator of Wnt signaling | Q24306307 |
| | Yap- and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development | Q27323992 |
| | The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression | Q28291847 |
| | Role of YAP/TAZ in mechanotransduction | Q29615411 |
| | Polarity-dependent distribution of angiomotin localizes Hippo signaling in preimplantation embryos. | Q34352631 |
| | Hippo signaling: growth control and beyond | Q34625638 |
| | NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway | Q35196050 |
| | Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance | Q35621419 |
| | Amot130 adapts atrophin-1 interacting protein 4 to inhibit yes-associated protein signaling and cell growth | Q36873676 |
| | Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation | Q36948973 |
| | ATM kinase enables the functional axis of YAP, PML and p53 to ameliorate loss of Werner protein-mediated oncogenic senescence. | Q37219985 |
| | The Ets transcription factor GABP is a component of the hippo pathway essential for growth and antioxidant defense. | Q37373544 |
| | Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation | Q37483196 |
| | Hippo signaling in mammalian stem cells | Q38049208 |
| | The Hippo pathway and human cancer. | Q38087215 |
| | Salt-inducible kinases regulate growth through the Hippo signalling pathway in Drosophila. | Q39221641 |
| | The Hippo pathway kinase Lats2 prevents DNA damage-induced apoptosis through inhibition of the tyrosine kinase c-Abl | Q41914260 |
| | Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene | Q42064207 |
| | Newcomers to the WW Domain-Mediated Network of the Hippo Tumor Suppressor Pathway | Q42731737 |
| | Hippo pathway regulation by cell morphology and stress fibers. | Q42806999 |
| | Altered Hippo signalling in polycystic kidney disease. | Q54607031 |
| P433 | issue | 21 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6389-6392 | |
| P577 | publication date | 2013-09-10 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | The hippo tumor suppressor network: from organ size control to stem cells and cancer | |
| P478 | volume | 73 | |